Inspiration Healthcare Group (IHC)

Sector:

Industrial Chemicals

Index:

FTSE AIM All-Share

 17.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 53.50p
  • 52 Week Low: 15.85p
  • Currency: UK Pounds
  • Shares Issued: 89.66m
  • Volume: 6,500
  • Market Cap: £15.47m
  • RiskGrade: 227

Inspiration Healthcare confident after weaker first-half

By Josh White

Date: Tuesday 04 Oct 2022

LONDON (ShareCast) - (Sharecast News) - Medical technology company Inspiration Healthcare reported total group revenue of £20.5m in its first half on Tuesday, down slightly from the £20.9m it recorded in the same period last year.
The AIM-traded firm said its gross margin for the six months ended 31 July slipped to 45.1%, from 52.5%, while branded products represented 54% of total group revenue, compared to 55% year-on-year.

EBITDA fell to £2.2m from £3.6m, and operating profit weakened to £1.1m from £2.6m, as the company's net cash position weakened to £3.3m at period end, from £8.6m a year earlier.

The board said the company's dividend for the first half remained unchanged, adding that it was "confident" in the profit forecast for the current financial year.

On the operational front, Inspiration noted its successful relocation into the new manufacturing and technology centre in south London.

It said it had prioritised securing its supply chain in the half-year by increasing stock, adding that it received large export orders from Iraq, worth £1.3m, and from Egypt, worth $1.4m.

European regulatory work and UKCA mark approval was also being prioritised, with "good progress" reported.

'Project WAVE' had now recruited 14 patients at University Hospitals Sussex, while the company's new distributed product, 'Genedrive', had been launched in Britain and Ireland.

"The first half of this financial year changed dramatically following the invasion of Ukraine by Russia and with further lockdowns in China," said chief executive officer Neil Campbell.

"These two events had an impact on supply chain and sales in our first half.

"Needless to say, the team has worked hard to ensure the business is in the best shape it could be, prioritising solutions to short term supply issues and offsetting delayed NHS orders by focussing on other areas of our portfolio."

Campbell said that, with production transferred to the company's new "state-of-the-art" manufacturing and technology centre, a "comprehensive and diverse range" of products and a "strong" order book, he was "impressed" with the resilience of the firm's team and business model.

"This resilience, along with the investment we have made in our infrastructure, stand us in good stead for the remainder of the financial year and for the longer term."

At 1313 BST, shares in Inspiration Healthcare Group were down 15.89% at 73.6p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

IHC Market Data

Currency UK Pounds
Share Price 17.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 53.50p
52 Week Low 15.85p
Volume 6,500
Shares Issued 89.66m
Market Cap £15.47m
RiskGrade 227

IHC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.22% above the market average65.22% above the market average65.22% above the market average65.22% above the market average65.22% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
88.26% below the market average88.26% below the market average88.26% below the market average88.26% below the market average88.26% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Income
89.56% below the market average89.56% below the market average89.56% below the market average89.56% below the market average89.56% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
94.25% below the market average94.25% below the market average94.25% below the market average94.25% below the market average94.25% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

IHC Dividends

  Latest Previous
  Interim Final
Ex-Div 23-Nov-23 29-Jun-23
Paid 22-Dec-23 28-Jul-23
Amount 0.20p 0.41p

Trades for 31-Oct-2024

Time Volume / Share Price
12:02 6,500 @ 17.20p

IHC Key Personnel

COO Brook Nolson
CFO Alan Olby

Top of Page